Andrea Sturchio

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Increased CSF DOPA Decarboxylase Correlates with Lower DaT‐SPECT Binding: Analyses in Biopark and PPMI Cohorts”.

Increased CSF DOPA Decarboxylase Correlates with Lower DaT‐SPECT Binding: Analyses in Biopark and PPMI Cohorts

Movement Disorders(2024)10.1002/mds.29835

N/A

0.360DataRank · unranked

10 citations

Andrea Sturchio, Ellen Appleton, Wojciech Pasławski, Michael Ta, Michael A. Nalls +4 more

How have advances in genetic technology modified movement disorder nosology?

European Journal of Neurology(2020)10.1111/ene.14294

N/A

0DataRank · unranked

10 citations

Luca Marsili, Abhimanyu Mahajan, Maria Barbara Grimberg, Marcelo Kauffman, Alberto J. Espay +1 more

Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies

Parkinsonism & Related Disorders(2020)10.1016/j.parkreldis.2020.11.008

N/A

0DataRank · unranked

6 citations

Matteo Gastaldi, Lucia Princiotta Cariddi, Daniela Biacchi, Alberto J. Espay, Diego Franciotta +3 more

Kinematic but not clinical measures predict falls in Parkinson-related orthostatic hypotension

Journal of Neurology(2020)10.1007/s00415-020-10240-8

N/A

0DataRank · unranked

19 citations

Alok Dwivedi, Luca Marsili, Aaron J. Hadley, Gabriele Sobrero, Dustin A. Heldman +7 more

DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease

Translational Neurodegeneration(2024)10.1186/s40035-024-00421-0

N/A

0DataRank · unranked

24 citations

Shervin Khosousi, Michael Ta, Michael A. Nalls, Andrew Singleton, Andrea Sturchio +5 more

High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease

Movement Disorders Clinical Practice(2025)10.1002/mdc3.70367

N/A

0DataRank · unranked

4 citations

Wojciech Pasławski, Shervin Khosousi, Ioanna Markaki, Michael A. Nalls, Andrew B. Singleton +3 more

The shift to a proteinopenia paradigm in neurodegeneration

Handbook of clinical neurology(2023)10.1016/b978-0-323-85555-6.00001-1

N/A

0DataRank · unranked

25 citations

Andrea Sturchio, Alberto J. Espay, Kariem Ezzat